lactic acid has been researched along with meropenem in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Block, F; Foltys, H; Lemmen, SW; Spitzer, C | 1 |
Chittaranjan, S; Doble, M; Geetha, V; Nandakumar, V | 1 |
1 review(s) available for lactic acid and meropenem
Article | Year |
---|---|
[Bacterial meningitis as a complication of Fusobacterium necroforum infection in adults].
Topics: Adult; Anti-Bacterial Agents; Blood Glucose; Cerebrospinal Fluid Proteins; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusobacterium necrophorum; Humans; Lactic Acid; Leukocyte Count; Lung Abscess; Meningitis, Bacterial; Meropenem; Metronidazole; Oculomotor Nerve Diseases; Otitis Media; Pharyngitis; Sepsis; Syndrome; Thienamycins | 2003 |
2 other study(ies) available for lactic acid and meropenem
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Escherichia coli; Lactic Acid; Meropenem; Mice; Models, Theoretical; Nanoparticles; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Thienamycins; Time Factors | 2013 |